VISOMITIN [Skulachev Ions | SKQ1 eye drops]


One part of SkQ1 functions as a molecular “tow truck” carrying the other part of the molecule – an extremely active antioxidant plastoquinone – into mitochondria. Both theoretical calculations and experimental results showed that SkQ1 was delivered into the mitochondria in an extremely targeted and efficient manner. The physics of the mitochondrial membrane and the unique properties of SkQ1 direct it into the inner leaflet of the inner mitochondrial membrane with high precision.

The mechanism of action of SkQ1 involves at least two extremely complex and novel concepts: delivering a compound inside mitochondria and reducing ROS production inside mitochondria in a controlled and sustainable manner. SkQ1 molecule successfully addresses these two aspects as our experimental work has shown.

More than a dozen studies have been conducted and showed SkQ1 effectiveness in such critical therapeutic areas as the following:

  • Age-related macular degeneration (AMD)
  • Dry eye syndrome (DES)
  • Non-infectious uveitis
  • Cataract
  • Glaucoma

Dosage and administration

Dosage is 1-2 drops 3 times a day. Duration of treatment is determined by the ophthalmologist individually, depending on the severity of symptoms and the dynamics of the pathological process in the eyes. Average treatment period is two to six months. During complex treatment of senile cataract held periodic medical examination ophthalmologist to appoint a possible surgical intervention on the lens of the eye.

Side effects

As a side effects after application local reactions in the eye in the form of a burning sensation, cramps, redness of the conjunctiva can develop.

Rare side effects: systemic allergic reactions such as skin rashes, itching, urticaria (a characteristic rash and swelling, which in appearance resemble the sting).

Cases of severe allergic reactions in the form of angioedema, or anaphylactic shock (a progressive decrease in systemic blood pressure and organ failure) were not observed.


There is no data on overdose with topical application.


Using eye drops Vizomitin is contraindicated in case of individual intolerance or hypersensitivity to the active ingredient and auxiliary ingredients. Also, the drug cannot be used by children under 18 years.

Note: the product should be kept in the fridge after receiving.